| Date | Title | Description |
| 16.06.2026 | SonoThera Secures $125M: Ultrasound Reshapes Genetic Medicine | SonoThera, a biotechnology pioneer, just closed a significant Series B funding round. The South San Francisco-based firm secured $125 million. This oversubscribed financing fuels its revolutionary nonviral genetic medicine platform. The inv... |
| 10.06.2026 | SonoThera Raises $125M in Series B Funding | SonoThera, a South San Francisco, CA-based biotechnology company developing new genetic medicines, raised $125M in Series B funding.
The round was led by Vida Ventures, with participation from ARK Invest, CureDuchenne Ventures, Leaps by Bay... |
| 10.06.2026 | SonoThera Raises $125 Million Series B To Advance Ultrasound-Mediated Genetic Medicines | SonoThera, a biotechnology company developing ultrasound-mediated nonviral genetic medicines, announced the closing of an oversubscribed $125 million Series B financing round to support the clinical advancement of its lead programs for Duch... |
| 14.05.2026 | Create Medicines Raises $122M in Series B Funding | Create Medicines, Inc., a Cambridge, Massachusetts-based developer of in vivo immune programming and mRNA-LNP cell therapies, raised $122m in Series B funding.
The round was co-led by existing investors Newpath Partners, ARCH Venture Partne... |
| 12.11.2025 | AI-Driven Biotech Iambic Secures Over $100M for Drug Discovery | Iambic, a San Diego AI-driven biotech, secured over $100M in funding. This capital fuels its advanced AI drug discovery platform and expanding clinical pipeline. The company rapidly advances novel therapies, like IAM1363, showing strong ant... |
| 11.11.2025 | Iambic Raises Over $100M in Funding | Iambic, a San Diego, CA-based clinical-stage life science and technology company developing novel medicines using its AI-driven discovery and development platform, raised over $100M in funding.
Backers included Abingworth, Alexandria Ventur... |
| 08.11.2025 | Accipiter Biosciences Secures $12.7M Seed Funding, Revolutionizing Protein Therapies | Accipiter Biosciences, a Seattle biotech, exited stealth with $12.7 million in seed funding. The company pioneers de novo multifunctional protein therapeutics. Its computational platform designs novel biologics from scratch. These single mo... |
| 07.11.2025 | Accipiter Biosciences: $12.7 Million Seed Funding Closed To Develop De Novo Protein Therapies | Accipiter Biosciences has emerged from stealth with $12.7 million in seed funding to advance a new class of de novo multifunctional protein therapeutics designed to treat complex diseases. The seed round was co-led by Takeda and Flying Fish... |
| 22.10.2025 | EQT Life Sciences’ ImCheck Therapeutics to be acquired by Ipsen in a transaction valued at up to EUR 1 billion | EQT Life Sciences’ ImCheck Therapeutics to be acquired by Ipsen in a transaction valued at up to EUR 1 billion
Wed, Oct 22, 2025 09:20 CET Report this content
Ipsen and ImCheck Therapeutics have entered into a definitive share purchase agre... |
| 17.10.2025 | Affinia Therapeutics: $40 Million Series C Raised For Advancing Gene Therapies For Cardiovascular And Neurological Diseases | Affinia Therapeutics, a biotechnology company pioneering engineered adeno-associated virus (AAV) gene therapies for severe cardiovascular and neurological conditions, has announced the closing of a $40 million Series C financing round. The ... |
| 15.10.2025 | Nilo Therapeutics Secures $101M for Neuro-Immunology Revolution | Nilo Therapeutics launched with $101 million Series A funding. The neuro-immunology biotech seeks to restore immune balance. It modulates neural circuits, targeting autoimmune and inflammatory diseases. Key investors include The Column Grou... |
| 09.10.2025 | Nilo Therapeutics Raises $101M in Series A Financing | Nilo Therapeutics, a NYC-based biotechnology company harnessing neural circuits to restore immune homeostasis in disease, launched with a $101m Series A financing.
The round was led by The Column Group (TCG), DCVC Bio, and Lux Capital, with... |
| 08.10.2025 | Immunology biotech Nilo launches with $101M and mission to harness neural circuits | Nilo Therapeutics has launched with $101 million in series A funds to drive its ambition to harness neural circuits to restore immune homeostasis.
The New York-headquartered company was founded by a trio of respected academics in Columbia U... |
| 01.10.2025 | Crystalys Therapeutics: $205 Million Series A Raised For Transforming Gout Treatment | Crystalys Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for gout, a condition characterized by high levels of uric acid in the blood that can lead to painful arthritis flare-ups. The... |
| 30.09.2025 | Crystalys Therapeutics Raises in $205M Series A Funding | Crystalys Therapeutics, a San Diego, CA-based clinical-stage biopharmaceutical company, raised $205M in Series A funding.
The round was led by Novo Holdings, SR One and Catalys Pacific with participation from a broad syndicate of investors,... |
| 12.09.2025 | Congruence Therapeutics: $32 Million Financing Raised For Advancing Genetic Obesity Therapy | Congruence Therapeutics has secured a $32 million financing round to support the development of its lead candidate CGX-926, the first clinical therapy designed to treat MC4R-deficient genetic obesity. The proceeds will fund a Phase 1 trial ... |
| 30.08.2025 | Leal Therapeutics: $30 Million Series A Secured To Advance Breakthrough CNS Therapies | Leal Therapeutics, a biotechnology company pioneering novel treatments for central nervous system (CNS) disorders, has announced the closing of a $30 million Series A financing round. The round was led by SV Health Investors’ Dementia Disco... |
| 25.07.2025 | Dispatch Bio Launched With $216 Million To Develop Solid Tumor Treatments | Dispatch Bio has officially launched with a mission to create a universal treatment for solid tumors, which constitute roughly 90% of cancers. The company has secured a total of $216 million in funding, including a recent Series A round.
Th... |
| 24.07.2025 | Dispatch Bio Raises Series A in Funding; Total To $216M | Dispatch Bio, a San Francisco, CA- and Philadelphia, PA-based Biotechnology company developing treatments for tumours, raised an undisclosed amounting Series A funding.
Backers included ARCH Venture Partners and PICI, along with Bristol Mye... |
| 04.06.2025 | The Shifting Landscape of Office Space: A New Era in Commercial Real Estate | The office space market is undergoing a seismic shift. For the first time in over 25 years, more office space is being removed than added. This trend marks a pivotal moment in the commercial real estate sector. The pandemic has left its mar... |
| 04.06.2025 | The Shifting Landscape of Commercial Real Estate: A Tale of Transformation | The commercial real estate market is undergoing a seismic shift. For the first time in decades, more office space is being removed than added. This change is not just a statistic; it’s a reflection of evolving work habits and economic reali... |
| 02.06.2025 | More office space is being removed than added for the first time in at least 25 years | More office space is set to be removed than added this year, shrinking the overall office footprint.
Office vacancies soared to a record high and still hover right around there at 19%.
Developers also have another 85 million square feet of ... |
| 08.05.2025 | HAYA Therapeutics: Pioneering the Future of RNA-Guided Therapies | In the world of biotechnology, innovation is the lifeblood. HAYA Therapeutics has just secured a hefty $65 million in Series A funding, a financial boost that could change the landscape of chronic and age-related disease treatment. This fun... |
| 08.05.2025 | HAYA Therapeutics banks $65 million Series A funding |
HAYA Therapeutics is a biotechnology company pioneering precision RNA-guided regulatory genome targeting therapeutics that reprogram disease-driving cell states for rare, common, chronic and age-related diseases. The core of HAYA’s proprie... |
| 28.04.2025 | Morning Bid: The toll from Trump's tariffs | Morning Bid: The toll from Trump's tariffs
By Mike DolanApril 28, 202510:52 AM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
CommentaryBy Mike Dolan
A futures-options trader works on the floor at... |
| 02.04.2025 | Artis BioSolutions Raises Funding; Acquires Landmark Bio | Artis BioSolutions, a San Diego, CA-based company which specializes in the development and production of genetic medicines, raised an undisclosed amount in funding.
The round was led by Oak HC/FT.
The company intends to use the funds to fur... |
| 06.03.2025 | Exclusive: AI-powered plant breeding startup Avalo raises $11m, partners with Coca Cola to future proof sugarcane production | Avalo—a startup deploying interpretable artificial intelligence to develop climate resilient crops—has raised an $11 million Series A round and entered into a partnership with CCEP to futureproof its sugarcane supply chain and reduce scope ... |
| 10.09.2024 | Alexandria Real Estate Equities, Inc. Executive Chairman and Founder Joel S. Marcus to Be Honored With the Inaugural Bisnow Life Sciences Icon & Influencer Award | PASADENA, Calif., Sept. 10, 2024 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, preeminent, longest-tenured and pioneering owner, operator and developer of collaborative mega campuses in AAA life science innov... |
| 15.08.2024 | Lilly's New Innovation Center: A Beacon for Biotech in Boston | Eli Lilly and Company has unveiled a new chapter in its storied history with the opening of the Lilly Seaport Innovation Center (LSC) in Boston. This state-of-the-art facility is not just a building; it’s a lighthouse guiding the future of ... |
| 13.08.2024 | Lilly opens state-of-the-art research and development center in the Boston Seaport | Lilly Seaport Innovation Center (LSC) serves as the central hub for Lilly's genetic medicines efforts and houses the first East Coast Lilly Gateway Labs
New 346,000 square foot facility will accommodate approximately 500 Lilly scientists an... |
| 03.08.2024 | Outpace Bio: A New Dawn in Cancer Treatment with AI-Powered Cell Therapies | In the realm of cancer treatment, innovation is the lifeblood. Outpace Bio is injecting fresh vigor into this field with its recent $144 million Series B financing. This funding, led by RA Capital Management, is a beacon of hope for patient... |
| 01.08.2024 | Outpace Bio Secures $144M for AI-Powered Cell Therapy Platform | What You Should Know:
– Outpace Bio, a pioneering cell therapy company raises $144M in oversubscribed Series B financing round led by RA Capital Management with participation from both new and existing investors, including Qatar Investment ... |
| 29.07.2024 | Deals in brief: Hive Health raises USD 6.5 million, AgFunder VC closes fourth early-stage fund, ten China and India deals, and more | Hive Health raises USD 6.5 million in pre-Series A round
Hive Health, a health insurance company based in Manila, has raised USD 6.5 million in a pre-Series A funding round. Key investors include Gentree Fund and Beenext, with participation... |
| 17.06.2024 | Bright Peak Therapeutics raises USD90 million to advance lead program into clinical trials |
Bright Peak Therapeutics is a biotechnology company advancing a portfolio of multifunctional immunotherapies to treat cancer and other diseases. “We are now well positioned to bring much needed innovation to the field of anti-PD-1 immune-c... |
| 22.05.2024 | Exploring real estate investment opportunities abroad? Know key risks here | - |
| 06.05.2024 | OverT Bio Secures $16M to Optimize Cell Therapy for Solid Tumors | What You Should Know:
– OverT Bio, a data-driven biotech company focused on unlocking the curative potential of cell therapies for solid tumors raises $16M in seed funding round. Co-led by ARTIS Ventures and Wing VC, the round saw participa... |
| 11.03.2024 | Umaro Foods: Seaweed Bacon Revolution | Umaro Foods, the Californian plant-based meat producer, has secured $3.8 million in funding to launch its innovative seaweed bacon into supermarkets. Led by AgFunder, the financing round aims to reduce production costs and expand the reach ... |
| 06.03.2024 | Umaro Foods raises $3.8m in new financing as it scales up meat-free bacon ‘at half the cost’ of animal bacon | [Disclosure: AgFunderNews’ parent company, AgFunder, is an investor in Umaro Foods.]
Umaro Foods has raised $3.8m in new financing including a seed 2 equity round led by AgFunder and grant funding as it gears up to launch its seaweed-based ... |
| 24.01.2024 | Elo Life Systems raises $20.5m in series A2, aims to launch natural sweetener in 2026: ‘Everyone is trying to reduce sugar’ | North Carolina-based Elo Life Systems has closed a $20.5 million Series A2 round to accelerate the development of a natural high-intensity sweetener and Cavendish bananas engineered to resist the devastating Fusarium wilt fungal disease (TR... |
| 25.10.2023 | Developer delivers 120-square-foot life science innovation hub to The Woodlands | A new innovation hub mega campus has opened in The Woodlands.
The Alexandria Center for Advanced Technologies at The Woodlands comes courtesy of California-based Alexandria Real Estate Equities Inc. The campus is home to the first purpose-b... |
| 22.08.2022 | Seattle startup aiming to detect, treat Alzheimer’s and Parkinson’s disease raises cash | AltPep CEO and founder Valerie Daggett. (AltPep Photo)
The news: University of Washington spinout AltPep recently raised $44.4 million, according to a regulatory filing. The company declined to discuss the filing, but founder and CEO Valeri... |
| 10.08.2022 | The women writing checks: A list of female venture capitalists in the Pacific Northwest | Back in 2018, GeekWire published a list of women investors based in the Pacific Northwest who were writing checks to help startups grow.
A lot has changed in four years. We’ve put together a new compilation below, highlighting more than 60 ... |
| 10.06.2022 | The Navy SEAL Foundation Honors Los Angeles Rams Owner/Chairman Stanley Kroenke with Patriot Award | Los Angeles Rams Owner/Chairman E. Stanley Kroenke and Navy SEAL Foundation CEO Robin King at the NSF Los Angeles Evening of Tribute To the Navy SEALS, we are grateful for your incredible bravery and selflessness, and we appreciate your tre... |
| 09.05.2022 | BREAKING: Brightseed bags $68m Series B funding from Temasek, AgFunder, others to launch ingredients biz | Disclosure: AFN’s parent company, AgFunder, is an investor in Brightseed.
US nutrient discovery company Brightseed has raised $68 million in funding as it scales up its novel ingredients business.
Singapore sovereign fund Temasek led the Se... |
| 01.04.2022 | Umaro’s $3m AgFunder-led seed round hints at a ocean-based future for alternative protein | Disclosure: AFN’s parent company, AgFunder, is an investor in Umaro Foods.
California’s Umaro Foods has raised $3 million in seed funding for its technology that turns seaweed into a protein source and functional ingredient for meat analogs... |
| 24.03.2022 | The Week in Agrifoodtech: African startups Apollo, Wasoko & ThriveAgric close big-ticket rounds | This has been a watershed week for African agrifoodtech, with a string of startups from the continent closing eight and nine-figure US dollar rounds over the past few days. Kenya’s Wasoko and Apollo Agriculture raised $125 million and $40 m... |
| 22.03.2022 | AgFunder captures increasing, urgent investor demand for agrifoodtech with $60m Fund IV first close | Disclosure: AgFunder is AFN’s parent company.
AgFunder, one of the world’s most active investors in foodtech and agtech startups, has increased its assets under management to $160 million – 10x in two years – with the first close of its fou... |
| 03.02.2022 | Alexandria Real Estate Equities, Inc. Announces Pricing of Public Offering of $800,000,000 of Senior Notes due 2034 $1,000,000,000 of Senior Notes due 2052 | PASADENA, Calif., Feb. 2, 2022 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) today announced that it has priced a public offering of $800,000,000 aggregate principal am... |
| 02.02.2022 | Alexandria Real Estate Equities, Inc. Announces Public Offering of Senior Notes | PASADENA, Calif., Feb. 2, 2022 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) today announced that it is commencing an underwritten public offering, subject to market co... |
| 28.01.2022 | Alexandria Venture Investments Commits Over $100M to Climate Change Technology Related Investments in 2021 | PASADENA, Calif., Jan. 28, 2022 /PRNewswire/ -- Alexandria Venture Investments, the strategic venture capital platform of Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT and the first, longest-tenured and pioneering ... |
| 27.01.2022 | Alexandria Real Estate Equities, Inc. Announces Tax Treatment of Year 2021 Distributions | PASADENA, Calif., Jan. 27, 2022 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE) today announced the tax treatment of its year 2021 distributions as described in the chart below. Stockholders are encouraged to consult with ... |
| 19.01.2022 | ALEXANDRIA REAL ESTATE EQUITIES, INC. ANNOUNCES UNDERWRITERS' EXERCISE AND CLOSING OF OPTION TO PURCHASE ADDITIONAL 1,050,000 SHARES OF COMMON STOCK | PASADENA, Calif., Jan. 18, 2022 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) today announced that the underwriters of its previously announced underwritten public offe... |
| 11.01.2022 | Alexandria Venture Investments Achieves Fifth Consecutive Annual #1 Most Active Corporate Investor in Biopharma | PASADENA, Calif., Jan. 10, 2022 /PRNewswire/ -- Alexandria Venture Investments, the strategic venture capital platform of Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT and the first, longest-tenured and pioneering ... |
| 08.01.2022 | ALEXANDRIA REAL ESTATE EQUITIES, INC. ANNOUNCES CLOSING OF PUBLIC OFFERING OF 7,000,000 SHARES OF COMMON STOCK | PASADENA, Calif., Jan. 7, 2022 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) today announced the closing of its previously announced underwritten public offering of 7,0... |
| 05.01.2022 | ALEXANDRIA REAL ESTATE EQUITIES, INC. ANNOUNCES PRICING OF UPSIZED PUBLIC OFFERING OF 7,000,000 SHARES OF COMMON STOCK | PASADENA, Calif., Jan. 4, 2022 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) today announced the pricing of its upsized public offering of 7,000,000 shares of the Compa... |
| 05.01.2022 | ALEXANDRIA REAL ESTATE EQUITIES, INC. ANNOUNCES PUBLIC OFFERING OF 6,500,000 SHARES OF COMMON STOCK | PASADENA, Calif., Jan. 4, 2022 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) today announced that it is commencing an underwritten public offering of 6,500,000 shares o... |
| 14.12.2021 | Alexandria Real Estate Equities, Inc. Enhances Its Pioneering Social Responsibility Initiatives by Enabling the Non-Profit Camp Kita to Further Its Mission to Support Children Impacted by Suicide | PASADENA, Calif., Dec. 14, 2021 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT and the first, longest-tenured and pioneering owner, operator and developer uniquely focused on collaborative life scien... |
| 30.11.2021 | Alexandria Real Estate Equities, Inc. to Hold Its Fourth Quarter and Year End 2021 Operating and Financial Results Conference Call and Webcast on February 1, 2022 | PASADENA, Calif., Nov. 30, 2021 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE) today announced that the company will conduct a conference call and audio webcast on Tuesday, February 1, 2022, at 3:00 p.m. Eastern Time (ET)... |
| 29.11.2021 |
Alexandria Venture Investments Ramps Investment Activity
| Pasadena-based Alexandria Venture Investments, the venture arm of Alexandria Real Estate Equities, says that has been ranked as one of the year's top five most active U.S. investors in the "agrifoodtech" sector. According to the c... |
| 29.11.2021 | Alexandria Venture Investments, One of the Year's Top Five Most Active U.S. Investors in Agrifoodtech, Accelerates Its Mission-Critical Investment Activity in a Sector Experiencing Tremendous Upsurge ... | PASADENA, Calif., Nov. 29, 2021 /PRNewswire/ -- Alexandria Venture Investments, the strategic venture capital platform of Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT and the first, longest-tenured and pioneering ... |
| 16.11.2021 | Alexandria Real Estate Equities, Inc. Is Leading the Integration of Mission-Critical R&D and Next-Gen Manufacturing for Companies in Research Triangle That Are Developing Targeted Gene and Cell Th... | PASADENA, Calif. and DURHAM, N.C., Nov. 16, 2021 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT and the first, longest-tenured and pioneering owner, operator and developer uniquely focused on collabo... |
| 05.11.2021 | Alexandria Real Estate Equities, Inc. to Join the National Medal of Honor Museum Foundation at Dallas Cowboys' 'Salute to Service' Game, to Celebrate the Company's Long-Term Support and Raise Awarenes... | PASADENA, Calif., Nov. 5, 2021 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT and the first, longest-tenured and pioneering owner, operator and developer uniquely focused on collaborative life scienc... |
| 25.10.2021 | Alexandria Real Estate Equities, Inc., at the Vanguard of the Life Science Industry, Providing High-Quality Office/Laboratory Space to Meet Historic-High Demand, Reports: 3Q21 and YTD 3Q21 Net Income ... | PASADENA, Calif., Oct. 25, 2021 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE:ARE) announced financial and operating results for the third quarter ended September 30, 2021.
Key highlights YTD Operating results 3Q21 3Q20 3Q21 3... |
| 18.10.2021 | Alexandria Real Estate Equities : Venture Investments Maintains Recognition as #1 Most Active Early-Stage Life Science Investor | PASADENA, Calif., Oct. 18, 2021 /PRNewswire/ -- Alexandria Venture Investments, the strategic venture capital platform of Alexandria Real Estate Equities, Inc. (NYSE:ARE), an urban office REIT and the first, longest-tenured and pioneering o... |
| 15.10.2021 | Alexandria Real Estate Equities, Inc. : Recognized for Continued ESG Leadership and Performance in the 2021 GRESB Assessment | PASADENA, Calif., Oct. 15, 2021 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT and the first, longest-tenured and pioneering owner, operator and developer uniquely focused on collaborative life scien... |
| 30.09.2021 | Alexandria Real Estate Equities, Inc. : Deepens and Expands Strategic Relationship With Moderna for New 462,000 RSF HQ and R&D Facility at 325 Binney Street, Designed to Be the Most Sustainable La... | PASADENA, Calif. and CAMBRIDGE, Mass., Sept. 30, 2021 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT and the first, longest-tenured and pioneering owner, operator and developer uniquely focused on co... |
| 01.09.2021 | The Week in Agrifoodtech: Toast files for IPO, Pinduoduo commits $1.5bn to ag | In news from the world of foodtech and agtech over the past seven days, restaurant payments platform Toast filed for an IPO in the US; while VC firm AgFunder closed its latest alt-protein fund, New Carnivore, on $21 million [disclosure: AgF... |
| 31.08.2021 | Alexandria Real Estate Equities, Inc. : to Hold Its Third Quarter 2021 Operating and Financial Results Conference Call and Webcast on October 26, 2021 | PASADENA, Calif., Aug. 31, 2021 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE) today announced that the company will conduct a conference call and audio webcast on Tuesday, October 26, 2021, at 3:00 p.m. Eastern Time (ET)... |
| 26.08.2021 | AgFunder raises $21m for New Carnivore alt-protein fund from ADM, Alexandria & others | Disclosure: AgFunder is AFN’s parent company.
Agrifoodtech VC AgFunder has announced the final close of New Carnivore, its alternative protein fund, on $21 million.
The fund was oversubscribed, surpassing its hard cap.
ADM Ventures, the VC ... |
| 05.08.2021 | AgFunder exit review: John Deere’s $250m acquisition of Bear Flag Robotics | Editor’s note: Bear Flag Robotics, an agtech startup focused on automation, has been acquired by John Deere for $250 million. Bear Flag Robotics was a portfolio company of agrifoodtech VC AgFunder, which is AFN’s parent company.
Here, AgFun... |
| 05.08.2021 | AgFunder exit review: John Deere’s $250m acquisition of Bear Flag Robotics | Editor’s note: Bear Flag Robotics, an agtech startup focused on automation, has been acquired by John Deere for $250 million. Bear Flag Robotics was a portfolio company of agrifoodtech VC AgFunder, which is AFN’s parent company. Here, AgFun... |
| 29.06.2021 | Alexandria Real Estate Equities, Inc. : Releases 2020 ESG Report Highlighting Its Pioneering Sustainability and Social Impact Leadership | PASADENA, Calif., June 29, 2021 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT and the first, longest-tenured and pioneering owner, operator and developer uniquely focused on collaborative life scien... |
| 22.06.2021 | Alexandria Real Estate Equities, Inc. : Announces Underwriters' Exercise And Closing Of Option To Purchase Additional 1,050,000 Shares Of Common Stock | PASADENA, Calif., June 22, 2021 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) today announced that the underwriters of its previously announced underwritten public offe... |
| 17.06.2021 | ALEXANDRIA REAL ESTATE EQUITIES, INC.
Alexandria Real Estate Equities, Inc. : Announces Closing of Public Offering of 7,000,000 Shares of Common Stock | PASADENA, Calif., June 17, 2021 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) today announced the closing of its previously announced underwritten public offering of 7,... |
| 15.06.2021 | ALEXANDRIA REAL ESTATE EQUITIES, INC.
Alexandria Real Estate Equities, Inc. : Announces Pricing Of Upsized Public Offering Of 7,000,000 Shares Of Common Stock | PASADENA, Calif., June 14, 2021 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) today announced the pricing of its upsized public offering of 7,000,000 shares of the Comp... |
| 14.06.2021 | ALEXANDRIA REAL ESTATE EQUITIES, INC.
Alexandria Real Estate Equities, Inc. : Announces Public Offering Of 6,500,000 Shares Of Common Stock | PASADENA, Calif., June 14, 2021 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) today announced that it is commencing an underwritten public offering of 6,500,000 shares ... |
| 14.06.2021 | Bright Peak Therapeutics Closes $107 Million Financing Round | |
| 25.05.2021 | BREAKING: Invaio raises $89m to accelerate commercialization of its injectable bio-inputs | Invaio Sciences has raised $88.9 million in a Series C round led by venture builder Flagship Pioneering, which launched the startup in 2018. Other investors joining the round include Stage 1 Ventures, Bluwave Capital, and Alexandria Venture... |
| 25.05.2021 | Invaio raises $89m to accelerate commercialization of its injectable bio-inputs | Invaio Sciences has raised $88.9 million in a Series C round led by venture builder Flagship Pioneering, which launched the startup in 2018. Other investors joining the round include Stage 1 Ventures, Bluwave Capital, and Alexandria Venture... |
| 25.05.2021 | ALEXANDRIA REAL ESTATE EQUITIES, INC.
Alexandria Real Estate Equities, Inc. : to Hold Its Second Quarter 2021 Operating and Financial Results Conference Call and Webcast on July 27, 2021 | PASADENA, Calif., May 25, 2021 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE) today announced that the company will conduct a conference call and audio webcast on Tuesday, July 27, 2021, at 3:00 p.m. Eastern Time (ET), in... |
| 26.04.2021 | ALEXANDRIA REAL ESTATE EQUITIES, INC.
Alexandria Real Estate Equities, Inc. Reports: 1Q21 Net Income per Share - Diluted of $0.04; 1Q21 FFO per Share - Diluted, As Adjusted, of $1.91; and Alexandria ... | PASADENA, Calif., April 26, 2021 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE:ARE) announced financial and operating results for the first quarter ended March 31, 2021.
Key highlights Operating results 1Q21 1Q20
Total revenue... |
| 12.03.2021 | Brief: Alexandria REIT to form $313m agrifoodtech SPAC | Alexandria Agtech/Climate Innovation Acquisition, a special purpose acquisition company (SPAC) formed by US real estate investment trust Alexandria Real Estate Equities, has filed with the US Securities & Exchange Commission to raise up... |
| 12.03.2021 | Brief: Alexandria REIT to form $250m agrifoodtech SPAC | Alexandria Agtech/Climate Innovation Acquisition, a special purpose acquisition company (SPAC) formed by US real estate investment trust Alexandria Real Estate Equities, has filed with the US Securities & Exchange Commission to raise up... |
| 16.11.2020 | ALEXANDRIA REAL ESTATE EQUITIES, INC.
Alexandria Real Estate Equities, Inc. : Achieves the World's First WELL Health-Safety Rating for Laboratory Space at Alexandria LaunchLabs in New York City | PASADENA, Calif., Nov. 16, 2020 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT and the first, longest-tenured and pioneering owner, operator and developer uniquely focused on collaborative life scien... |
| 16.11.2020 | Alexandria Real Estate Equities, Inc. : Achieves the World's First WELL Health-Safety Rating for Laboratory Space at Alexandria LaunchLabs in New York City | PASADENA, Calif., Nov. 16, 2020 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT and the first, longest-tenured and pioneering owner, operator and developer uniquely focused on collaborative life scien... |
| 02.07.2020 | TerMir wins Alexandria’s inaugural AgTech Innovation Prize | Our mission at Alexandria Real Estate Equities, Inc. (NYSE: ARE) is to create and cultivate collaborative, innovation clusters that enable breakthroughs to advance human health and improve nutrition; this mission is now more important than ... |
| 20.02.2020 | The evolution of New York City as a bioinnovation hub highlighted in new report | Three years ago, in its inaugural report on the venture capital landscape, New York City Health Business Leaders calculated that 79 startups and growth stage companies received $703 million in 2017. To put that in a national perspective, St... |
| 15.01.2020 | Alexandria LaunchLabs opens $100k agtech pitch competition – apply by Jan 31! | Are you an agtech entrepreneur looking for a little capital to take your idea to the next level? Alexandria LaunchLabs – AgTech is looking for early-stage startups to compete in an expenses-paid, in-person pitch competition in North Carolin... |
| 01.04.2019 | Alexandria Absorbs AgTech Accelerator into Seed Capital Platform and LaunchLabs in RTP | Alexandria Real Estate Equities, the real estate investment trust (REIT) focused on life sciences and technology campuses, has launched a multi-faceted agtech investment strategy including physical facilities for agtech businesses to operat... |
| 24.09.2018 | MouSensor Closes a $3.3M Seed Round | MouSensor, Inc., a biotechnology company that develops a novel and potentially transformative platform to digitize the sense of smell, announced today that it has raised $3.3M in its seed round. The seed round was co-led by imec.xpand and A... |
| 23.09.2018 | Celgene Joins $47.5M Series A for Silverback Therapeutics | Silverback Therapeutics, Inc., a biotechnology company developing a pipeline of systemically delivered, locally active therapies, has closed an extension of its Series A financing to bring the total raised in the round to $47.5 million. The... |
| 19.09.2018 | Silverback Therapeutics raises $37.5M, unveils tech that targets therapies to disease locations | Peter Thompson, co-founder and CEO of Silverback Therapeutics. (OrbiMed Advisors Photo)
Silverback Therapeutics, a stealthy biotechnology startup, gave the first glimpse of its technology Wednesday as it announced an additional $37.5 millio... |
| 08.01.2018 | Alexandria Seed Capital Platform Debuts | Alexandria Venture Investments, the strategic venture capital arm of Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT uniquely focused on collaborative life science and technology campuses in AAA innovation cluster lo... |
| 17.07.2017 | Ag Industry Brief: Agtech Startups Win Big at AI Competition, Adapt-N Reachs 1m Nitrogen Recommendations, more | Agtech Startups Win Big at CogX AI Innovation Challenge
Agtech startups won big at the recent CogX Innovation Exchange and Annual Awards in London, an event that brought together more than 350 of the world’s leading Artificial Intelligence ... |
| 03.04.2017 | Cydan Development Announces the Acquisition of Its First Rare Disease Spin-out, Vtesse, Inc. by Sucampo Pharmaceuticals, Inc. | Link to Release
Cambridge, Mass., April 3, 2017 – Cydan Development, Inc., an orphan drug accelerator dedicated to creating therapies that improve the lives of people living with rare genetic diseases, today announces that Vtesse, Inc., ... |
| 09.03.2017 | Agtech Funding (& Exit) Sheet: $84m Raised in 2 Weeks (+$400m Instacart Series D), Origin Acquires AgSpace | AgSpace, a UK ag big data startup, has been acquired by Origin Enterprises, the ag retailer and agronomy company for £11.4 million ($13.9m). A further payment of £4.8m ($5.9m) will be made if the company reaches its profit targets. AgSpace ... |
| 02.03.2017 | AgTech Accelerator Launches First Startup Bringing Gates Foundation to Boragen $10m Series A | AgTech Accelerator, the venture development organization, has launched its first startup, Boragen, leading a $10 million Series A for the ag biotech startup.
AgTech Accelerator invested $3 million of its current $20 million capital pool and... |
| 05.01.2017 | AgriMetis Raises $23.5m Series B for Natural Products-Derived Crop Protection Research – exclusive | AgriMetis, the crop protection spin-off from healthcare innovation firm Acidophil, has raised $23.5 million in Series B funding in an oversubscribed round led by Anterra Capital.
Joining the round and making a crossover investment from the ... |
| 30.09.2016 | Aura Biosciences, participada por Ysios Capital, cierra una ronda de $8 millones | 30/09/2016
AURA BIOSCIENCIES, PARTICIPADA POR YSIOS CAPITAL, CIERRA UNA RONDA DE $8 MILLONES.
Aura Biosciences, compañía biotecnológica participada por la entidad de capital riesgo (venture capital) Ysios Capital, ha anunciado el cierre d... |
| 13.06.2016 | NYC, Alexandria Real Estate Equities Launches Alexandria LaunchLabs and Seed Fund | Alexandria Real Estate Equities, Inc. (NYSE: ARE), a real estate investment trust focused on collaborative science and technology campuses in urban innovation clusters, has announced plans for Alexandria LaunchLabs and Alexandria Seed Fund.... |
